The DOI matches its Crossref record.
Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis
Abstract
Summary: A model of the clinical course of epilepsy from onset until remission or death has been developed for six prognostic groups, including survival, use and cost of medical care, and time lost from work and housekeeping. The model has been used to generate preliminary estimates of the lifetime cost of epilepsy for a cohort of persons diagnosed in 1990 in the United States. The distribution of incident cases among prognostic groups is derived from epidemiologic studies of prognosis in epilepsy. Direct cost is estimated by multiplying nationally representative unit costs by the expected type and frequency of medical care use. The latter were derived by an expert panel, based on inferences from existing literature and on their own clinical experiences. Indirect cost is estimated based on lost earnings associated with projections of restricted activity days, excess unemployment, and excess mortality. Total lifetime cost in 1990 dollars of all persons with epilepsy onset in 1990 was estimated at $3.0 billion, with indirect cost accounting for 62% of the total. Cost per patient ranged from $4,272 for persons with remission after initial diagnosis and treatment to $138,602 for persons with intractable and frequent seizures. Antiepileptic drug (AED) treatment is the most costly category of service. Different assumptions about the amount and type of drug administration cause major changes in overall cost estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Engel, J., Wiebe, S., French, J., Sperling, M., Williamson, P., Spencer, D., Gumnit, R., Zahn, C., Westbrook, E., & Enos, B. (2003) · Neurology · doi:10.1212/01.wnl.0000055086.35806.2d · Cited by 904
Begley, C. E., Famulari, M., Annegers, J. F., Lairson, D. R., Reynolds, T. F., Coan, S., Dubinsky, S., Newmark, M. E., Leibson, C., So, E. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00166.x · Cited by 599
Self-citationThe impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions
Fisher, R. S., Vickrey, B. G., Gibson, P., Hermann, B., Penovich, P., Scherer, A., & Walker, S. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00126-1 · Cited by 438
Engel, J., Wiebe, S., French, J., Sperling, M., Williamson, P., Spencer, D., Gumnit, R., Zahn, C., Westbrook, E., & Enos, B. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.48202.x · Cited by 400
THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES
Mohr, P. E., Feldman, J. J., Dunbar, J. L., McConkey-Robbins, A., Niparko, J. K., Rittenhouse, R. K., & Skinner, M. W. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300103162 · Cited by 398
Metadata
- Authors
- Begley, C. E., Annegers, J. F., Lairson, D. R., Reynolds, T. F., & Hauser, W. A.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1994-11
- Volume
- 35
- Issue
- 6
- Pages
- 1230-1243
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1997318373
- Cited by
- 242
- References
- 0
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis. https://app.cochat.ai/papers/10.1111/j.1528-1157.1994.tb01794.x
- The paper
- Begley, C. E., Annegers, J. F., Lairson, D. R., Reynolds, T. F., & Hauser, W. A. (1994). Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis. Epilepsia. https://doi.org/10.1111/j.1528-1157.1994.tb01794.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.